No photo of William Farnaby

View Scopus Profile

Farnaby, William

Mr

  • 52 Citations
  • 4 h-Index
20172019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where William Farnaby is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 39 Similar Profiles
Ubiquitin-Protein Ligases Medicine & Life Sciences
Proteolysis Medicine & Life Sciences
Chromatin Assembly and Disassembly Medicine & Life Sciences
Lysophosphatidic Acid Receptors Medicine & Life Sciences
Central Nervous System Agents Medicine & Life Sciences
Enzyme kinetics Chemical Compounds
Nucleosomes Medicine & Life Sciences
Drug Discovery Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2019

  • 52 Citations
  • 4 h-Index
  • 6 Article
  • 1 Editorial
15 Citations (Scopus)
14 Downloads (Pure)

BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design

Farnaby, W., Koegl, M., Roy, M. J., Whitworth, C., Diers, E., Trainor, N., Zollman, D., Steurer, S., Karolyi-Oezguer, J., Riedmueller, C., Gmaschitz, T., Wachter, J., Dank, C., Galant, M., Sharps, B., Rumpel, K., Traxler, E., Gerstberger, T., Schnitzer, R., Petermann, O. & 17 others, Greb, P., Weinstabl, H., Bader, G., Zoephel, A., Weiss-Puxbaum, A., Ehrenhöfer-Wölfer, K., Wöhrle, S., Boehmelt, G., Rinnenthal, J., Arnhof, H., Wiechens, N., Wu, M-Y., Owen-Hughes, T., Ettmayer, P., Pearson, M., McConnell, D. B. & Ciulli, A., Jul 2019, In : Nature Chemical Biology. 15, 7, p. 672-680 9 p.

Research output: Contribution to journal › Article

Open Access
File
Proteolysis
Adenosine Triphosphatases
Biophysics
Neoplasms
Chromatin Assembly and Disassembly

Protein degradation for drug discovery

Ciulli, A. & Farnaby, W., Apr 2019, In : Drug Discovery Today: Technologies. 31, p. 1-3 3 p.

Research output: Contribution to journal › Editorial

Publisher Correction: BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design

Farnaby, W., Koegl, M., Roy, M. J., Whitworth, C., Diers, E., Trainor, N., Zollman, D., Steurer, S., Karolyi-oezguer, J., Riedmueller, C., Gmaschitz, T., Wachter, J., Dank, C., Galant, M., Sharps, B., Rumpel, K., Traxler, E., Gerstberger, T., Schnitzer, R., Petermann, O. & 17 others, Greb, P., Weinstabl, H., Bader, G., Zoephel, A., Weiss-Puxbaum, A., Ehrenhöfer-Wölfer, K., Wöhrle, S., Boehmelt, G., Rinnenthal, J., Arnhof, H., Wiechens, N., Wu, M-Y., Owen-Hughes, T., Ettmayer, P., Pearson, M., Mcconnell, D. B. & Ciulli, A., 2 Jul 2019, In : Nature Chemical Biology. 15, 8, p. 846 1 p.

Research output: Contribution to journal › Article

Chromatin Assembly and Disassembly
Ubiquitin-Protein Ligases
Nucleosomes
DNA Repair
Chromatin
15 Citations (Scopus)
168 Downloads (Pure)

SPR-measured dissociation kinetics of PROTAC ternary complexes influence target degradation rate

Roy, M., Winkler, S., Hughes, S. J., Whitworth, C., Galant, M., Farnaby, W., Rumpel, K. & Ciulli, A., 15 Mar 2019, In : ACS Chemical Biology. 14, 3, p. 361-368 8 p.

Research output: Contribution to journal › Article

Open Access
File
Proteolysis
Enzyme kinetics
Degradation
Ubiquitin-Protein Ligases
Assays
2 Citations (Scopus)
157 Downloads (Pure)

Identification of compounds acting as negative allosteric modulators of the LPA 1 receptor

Ellery, J., Dickson, L., Cheung, T., Ciuclan, L., Bunyard, P., Mack, S., Buffham, W. J., Farnaby, W., Mitchell, P., Brown, D., Isaacs, R. & Barnes, M., 15 Aug 2018, In : European Journal of Pharmacology. 833, p. 8-15 8 p.

Research output: Contribution to journal › Article

Open Access
File
Lysophosphatidic Acid Receptors
Interferometry
Physiological Phenomena
Arrestin
Benzoic Acid